News Releases

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that it will be conducting a conference call to discuss the Trust’s previously announced debt and royalty…

– Transaction to Fund Launch and Commercialization of Pacritinib in the United States This Year Pending FDA Approval, and Future Commercialization – SEATTLE and TORONTO, Aug. 25, 2021 /CNW/ -…

– Quarter highlighted by strong performance from existing pharmaceutical products portfolio – TORONTO, Aug. 5, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”)…

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its 2021 second quarter financial results on Friday, August 6, 2021, at

DRI Healthcare Trust (TSX: DHT.U) (TSX: DHT.UN) (“DRI” or “the Trust”) today announced its results for the period ended March 31, 2021. The Trust’s first quarter 2021 financial statements and…

DRI Healthcare Trust (TSX: DHT.U) (TSX: DHT.UN) (the “Trust”) will release its 2021 first quarter financial results prior to market open on Monday, May 10, 2021. Management will host a conference…

The board of trustees of DRI Healthcare Trust (the “Trust”) (TSX: DHT.U) (TSX: DHT.UN) has approved the payment of a distribution of US$0.0167 per trust unit. The distribution will be paid on…

/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/ TORONTO, Feb. 19, 2021 /CNW/ – DRI Healthcare Trust (the “Trust”) (TSX: DHT.U) (TSX: DHT.UN), is pleased to announce…

/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/ TORONTO, Feb. 10, 2021 /CNW/ – DRI Healthcare Trust (the “Trust”) today announced that it has obtained a receipt for…